Clinical Trial Update: Hepatitis B Challenge Dose in Adults (V232-059-10) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for Hepatitis B exploring a challenge-dose in adults; the study is completed and results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis B | Phase 3 | Status: COMPLETED | Results posted: 2017-08-28